An enhanced packaging system for helper-dependent herpes simplex virus vectors

Journal of Virology

Volumn 72, Issue 9, 1998, Pages 7137-7143

  Stavropoulos, Tom A ^b   Strathdee, Craig A ^a  

^a ROBARTS RESEARCH INSTITUTE   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA; VIRUS VECTOR;

ARTICLE; ESCHERICHIA COLI; GENE AMPLIFICATION; GENE TARGETING; HERPES SIMPLEX VIRUS; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VIRUS REPLICATION;

EID: 0031870243     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.9.7137-7143.1998     Document Type: Article

References (44)

1. Breakefield, X. O., and N. A. DeLuca. 1991. Herpes simplex virus for gene delivery to neurons. New Biol. 3:203-218.
2. Chiocca, E. A., B. B. Choi, W. Z. Cai, N. A. DeLuca, P. A. Schaffer, M. DiFiglia, X. O. Breakefield, and R. L. Martuza. 1990. Transfer and expression of the lacZ gene in rat brain neurons mediated by herpes simplex virus mutants. New Biol. 2:739-746.
3. Chou, J., and B. Roizman. 1985. Isomerization of herpes simplex virus 1 genome: identification of the cis-acting and recombination sites within the domain of the a sequence. Cell 41:803-811.
4. Cunningham, C., and A. J. Davison. 1993. A cosmid-based system for constructing mutants of herpes simplex virus type 1. Virology 197:116-124.
5. Fink, D. J., N. A. DeLuca, W. F. Goins, and J. C. Glorioso. 1996. Gene transfer to neurons using herpes simplex virus-based vectors. Annu. Rev. Neurosci. 19:265-287.
6. Fraefel, C., D. R. Jacoby, C. Lage, H. Hilderbrand, J. Y. Chou, F. W. Alt, X. O. Breakefield, and J. A. Majzoub. 1997. Gene transfer into hepatocytes mediated by helper virus-free HSV/AAV hybrid vectors. Mol. Med. 3:813-825.
7. Fraefel, C., S. Song, F. Lim, P. Lang, L. Yu, Y. Wang, P. Wild, and A. I. Geller. 1996. Helper virus-free transfer of herpes simplex virus type 1 plasmid vectors into neural cells. J. Virol. 70:7190-7197.
8. Geller, A. I., and X. O. Breakefield. 1988. A defective HSV-1 vector expresses Escherichia coli beta-galactosidase in cultured peripheral neurons. Science 241:1667-1669.
9. Geller, A. I., K. Keyomarsi, J. Bryan, and A. B. Pardee. 1990. An efficient deletion mutant packaging system for defective herpes simplex virus vectors: potential applications to human gene therapy and neuronal physiology. Proc. Natl. Acad. Sci. USA 87:8950-8954.
10. Glorioso, J. C., W, F. Goins, D. J. Fink, and N. A. DeLuca. 1994. Herpes simplex virus vectors and gene transfer to brain. Dev. Biol. Stand. 82:79-87.
11. Ho, D. 1994. Amplicon-based herpes simplex virus vectors. Methods Cell Biol. 43:191-210.
12. Ho, D. Y., T. C. Saydam, S. L. Fink, M. S. Lawrence, and R. M. Sapolsky. 1995. Detective herpes simplex virus vectors expressing the rat brain glucose transporter protect cultured neurons from necrotic insults. J. Neuroehem. 65:842-850.
13. Huard, J., W. F. Goins, and J. C. Glorioso. 1995. Herpes simplex virus type 1 vector mediated gene transfer to muscle. Gene Ther. 2:385-392.
14. Johnson, P. A., A. Miyanohara, F. Levine, T. Cahill, and T. Friedmann. 1992. Cytotoxicity of a replication-defective mutant of herpes simplex virus type 1. J. Virol. 66:2952-2965.
15. Johnson, P. A., M. J. Wang, and T. Friedmann. 1994. Improved cell survival by the reduction of immediate-early gene expression in replication-defective mutants of herpes simplex virus type 1 but not by mutation of the virion host shutoff function. J. Virol. 68:6347-6362.
16. Johnson, P. A., K. Yoshida, F. H. Gage, and T. Friedmann. 1992. Effects of gene transfer into cultured CNS neurons with a replication-defective herpes simplex virus type 1 vector. Brain Res. Mol. Brain Res. 12:95-102.
17. Krisky, D. M., P. C. Marconi, T. Oligino, R. J. Rouse, D. J. Fink, and J. C. Glorioso. 1997. Rapid method for construction of recombinant HSV gene transfer vectors. Gene Ther. 4:1120-1125.
18. Lachmann, R. H., and S. Efstathiou. 1997. Utilization of the herpes simplex virus type 1 latency-associated regulatory region to drive stable reporter gene expression in the nervous system. J. Virol. 71:3197-3207.
19. Leib, D. A., and P. D. Olivo. 1993. Gene delivery to neurons: is herpes simplex virus the right tool for the job? Bioessays 15:547-554.
20. Lim, F., D. Hartley, P. Starr, P. Lang, S. Song, L. Yu, Y. Wang, and A. I. Geller. 1996. Generation of high-titer defective HSV-1 vectors using an IE 2 deletion mutant and quantitative study of expression in cultured cortical cells. BioTechniques 20:460-469.
21. MacGregor, G. R., A. E. Mogg, J. F. Burke, and C. T. Caskey. 1987. Histochemical staining of clonal mammalian cell lines expressing E. coli beta galactosidase indicates heterogeneous expression of the bacterial gene. Somat. Cell Mol. Genet. 13:253-265.
22. Messerle, M., I. Crnkovic, W. Hammerschmidt, H. Ziegler, and U. H. Koszinowski. 1997. Cloning and mutagenesis of a herpesvirus genome as an infectious bacterial artificial chromosome. Proc. Natl. Acad. Sci. USA 94: 14759-14763.
23. Paterson, T., and R. D. Everett. 1990. A prominent serine-rich region in Vmw 175, the major transcriptional regulator protein of herpes simplex virus type 1, is not essential for virus growth in tissue culture. J. Gen. Virol. 71: 1775-1783.
24. Pear, W. S., G. P. Nolan, M. L. Scott, and D. Baltimore. 1993. Production of high-titer helper-free retroviruses by transient transfection. Proc. Natl. Acad. Sci. USA 90:8392-8396.
25. Pechan, P. A., M. Fotaki, R. L. Thompson, R. Dunn, M. Chase, E. A. Chiocca, and X. O. Breakefield. 1996. A novel 'piggyback' packaging system for herpes simplex virus amplicon vectors. Hum. Gene Ther. 7:2003-2013.
26. Roizman, B. 1979. The structure and isomerization of herpes simplex virus genomes. Cell 16:481-494.
27. Roizman, B., A. B. Sears, and R. J. Whitley. 1996. Fields virology, 3rd ed. Lippincott-Raven, New York, N.Y.
28. Samaniego, L. A., L. Neiderhiser, and N. A. DeLuca. 1998. Persistence and expression of the herpes simplex virus genome in the absence of immediate-early proteins. J. Virol. 72:3307-3320.
29. Samaniego, L. A., N. Wu, and N. A. DeLuca. 1997. The herpes simplex virus immediate-early protein ICP0 affects transcription from the viral genome and infected-cell survival in the absence of ICP4 and ICP27. J. Virol. 71: 4614-4625.
30. Shizuya, H., B. Birren, U. J. Kim, V. Mancino, T. Slepak, Y. Tachiiri, and M. Simon. 1992. Cloning and stable maintenance of 300-kilobase-pair fragments of human DNA in Escherichia coli using an F-factor-bascd vector. Proc. Natl. Acad. Sci. USA 89:8794-8797.
31. Smibert, C. A., D. C. Johnson, and J. R. Smiley. 1992. Identification and characterization of the virion-induced host shutoff product of herpes simplex virus gene UL41. J. Gen. Virol. 73:467-470.
32. Smiley, J. R., C. Lavery, and M. Howes. 1992. The herpes simplex virus type 1 (HSV-1) α sequence serves as a cleavage/packaging signal but does not drive recornbinational genome isomerization when it is inserted into the HSV-2 genome. J. Virol. 66:7505-7510.
33. Smith, I. L., M. A. Hardwicke, and R. M. Sandri-Goldin. 1992. Evidence that the herpes simplex virus immediate early protein ICP27 acts post-transcriptionally during infection to regulate gene expression. Virology 186:74-86.
34. Spaete, R. R., and N. Frenkel. 1985. The herpes simplex virus amplicon: analyses of cis-acting replication functions. Proc. Natl. Acad. Sci. USA 82: 694-698.
35. Starr, P. A., F. Lim, F. D. Grant, L. Trask, P. Lang, L. Yu, and A. I. Geller. 1996. Long-term persistence of defective HSV-1 vectors in the rat brain is demonstrated by reactivation of vector gene expression. Gene Ther. 3:615-623.
36. Stevens, J. G. 1989. Human herpesviruses: a consideration of the latent state. Microbiol. Rev. 53:318-332.
37. Strathdee, C. A. 1996. Development of a hybrid herpesvirus vector for gene expression in mammalian tissues, abstr. W31-8. 15th Annual Meeting of the American Society for Virology.
38. Strathdee, C. A. Unpublished data.
39. Tischler, A. S., and L. A. Greene. 1978. Morphologic and cytochcmical properties of a clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Lab. Invest. 39:77-89.
40. Tsui, L. C., M. L. Breitman, L. Siminovitch, and M. Buchwald. 1982. Persistence of freely replicating SV40 recombinant molecules carrying a selectable marker in permissive simian cells. Cell 30:499-508.
41. Wang, S., and J. M. Vos. 1996. A hybrid herpesvirus infectious vector based on Epstein-Barr virus and herpes simplex virus type 1 for gene transfer into human cells in vitro and in vivo. J. Virol. 70:8422-8430.
42. Wu, N., S. C. Watkins, P. A. Schaffer, and N. A. DeLuca. 1996. Prolonged gene expression and cell survival after infection by a herpes simplex virus mutant defective in the immediate-early genes encoding ICP4, ICP27, and ICP22. J. Virol. 70:6358-6369.
43. Wu, X., Y. Leduc, M. Cynader, and F. Tufaro. 1995. Examination of conditions affecting the efficiency of HSV-1 amplicon packaging. J. Virol. Methods 52:219-229.
44. Zhang, X., H. O'Shea, C. Enrwisle, M. Boursnell, S. Efstathiou, and S. Inglis. 1998. An efficient selection system for packaging herpes simplex virus amplicons. J. Gen. Virol. 79:125-131.